BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16230338)

  • 1. Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation.
    Friedrich R; Panizzi P; Kawabata S; Bode W; Bock PE; Fuentes-Prior P
    J Biol Chem; 2006 Jan; 281(2):1188-95. PubMed ID: 16230338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes.
    Panizzi P; Friedrich R; Fuentes-Prior P; Richter K; Bock PE; Bode W
    J Biol Chem; 2006 Jan; 281(2):1179-87. PubMed ID: 16230339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions.
    Panizzi P; Friedrich R; Fuentes-Prior P; Kroh HK; Briggs J; Tans G; Bode W; Bock PE
    J Biol Chem; 2006 Jan; 281(2):1169-78. PubMed ID: 16230340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity and affinity of the N-terminal residues in staphylocoagulase in binding to prothrombin.
    Maddur AA; Kroh HK; Aschenbrenner ME; Gibson BHY; Panizzi P; Sheehan JH; Meiler J; Bock PE; Verhamme IM
    J Biol Chem; 2020 Apr; 295(17):5614-5625. PubMed ID: 32156702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation.
    Friedrich R; Panizzi P; Fuentes-Prior P; Richter K; Verhamme I; Anderson PJ; Kawabata S; Huber R; Bode W; Bock PE
    Nature; 2003 Oct; 425(6957):535-9. PubMed ID: 14523451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin.
    Kroh HK; Panizzi P; Bock PE
    Proc Natl Acad Sci U S A; 2009 May; 106(19):7786-91. PubMed ID: 19416890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding.
    Malkowski MG; Martin PD; Guzik JC; Edwards BF
    Protein Sci; 1997 Jul; 6(7):1438-48. PubMed ID: 9232645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The staphylocoagulase family of zymogen activator and adhesion proteins.
    Panizzi P; Friedrich R; Fuentes-Prior P; Bode W; Bock PE
    Cell Mol Life Sci; 2004 Nov; 61(22):2793-8. PubMed ID: 15558209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of zymogen domains and active site occupation on activation of prothrombin by von Willebrand factor-binding protein.
    Kroh HK; Bock PE
    J Biol Chem; 2012 Nov; 287(46):39149-57. PubMed ID: 23012355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation.
    Kroh HK; Tans G; Nicolaes GA; Rosing J; Bock PE
    J Biol Chem; 2007 Jun; 282(22):16095-104. PubMed ID: 17430903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the insertion loop around tryptophan 148 in tthe activity of thrombin.
    DiBella EE; Scheraga HA
    Biochemistry; 1996 Apr; 35(14):4427-33. PubMed ID: 8605192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From
    Farkas ÁZ; Farkas VJ; Szabó L; Wacha A; Bóta A; Csehi L; Kolev K; Thelwell C
    Front Immunol; 2019; 10():2967. PubMed ID: 31921206
    [No Abstract]   [Full Text] [Related]  

  • 13. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.
    Martin PD; Malkowski MG; Box J; Esmon CT; Edwards BF
    Structure; 1997 Dec; 5(12):1681-93. PubMed ID: 9438869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active site-labeled prothrombin inhibits prothrombinase in vitro and thrombosis in vivo.
    Kroh HK; Panizzi P; Tchaikovski S; Baird TR; Wei N; Krishnaswamy S; Tans G; Rosing J; Furie B; Furie BC; Bock PE
    J Biol Chem; 2011 Jul; 286(26):23345-56. PubMed ID: 21531712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-canonical proteolytic activation of human prothrombin by subtilisin from
    Pontarollo G; Acquasaliente L; Peterle D; Frasson R; Artusi I; De Filippis V
    J Biol Chem; 2017 Sep; 292(37):15161-15179. PubMed ID: 28684417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin.
    Kawabata S; Morita T; Iwanaga S; Igarashi H
    J Biochem; 1985 Dec; 98(6):1603-14. PubMed ID: 4093448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.
    Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
    Biochemistry; 1993 May; 32(18):4727-37. PubMed ID: 8387813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
    Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.